CUSIP: 58490H107
What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 58490H107:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$200,375 | $0.65 | 0 |
| 2024 Q4 | 175,000 | $200,375 | +$57,250 | $1.14 | 1 |
| 2024 Q3 | 125,000 | $175,000 | +$35,000 | $1.40 | 1 |
| 2024 Q2 | 100,000 | $145,000 | +$145,000 | $1.45 | 1 |
| 2024 Q1 | 0 | $0 | -$40,918 | $0.65 | 0 |
| 2023 Q4 | 128,978 | $40,918 | -$2,370,438 | $0.30 | 3 |
| 2023 Q3 | 8,281,040 | $2,409,139 | -$231,755 | $0.29 | 25 |
| 2023 Q2 | 8,617,865 | $4,146,703 | -$83,059 | $0.48 | 26 |
| 2023 Q1 | 8,762,397 | $5,596,089 | -$399,184 | $0.63 | 26 |
| 2022 Q4 | 9,595,263 | $4,431,339 | +$73,549 | $0.46 | 27 |
| 2022 Q3 | 9,786,252 | $8,116,000 | +$4,225,692 | $0.83 | 27 |
| 2022 Q2 | 3,924,831 | $4,568,000 | +$328,926 | $1.16 | 18 |
| 2022 Q1 | 4,209,660 | $5,444,000 | +$128,207 | $1.28 | 19 |
| 2021 Q4 | 4,083,323 | $6,665,000 | +$2,214,910 | $1.63 | 22 |
| 2021 Q3 | 2,659,809 | $7,369,000 | -$5,993,316 | $2.77 | 22 |
| 2021 Q2 | 4,631,996 | $13,969,982 | -$3,500,624 | $3.01 | 24 |
| 2021 Q1 | 5,147,177 | $20,935,722 | +$11,421,276 | $4.08 | 29 |
| 2020 Q4 | 2,304,565 | $10,774,123 | +$2,115,400 | $4.68 | 20 |
| 2020 Q3 | 1,755,051 | $7,237,374 | +$7,009,822 | $4.14 | 13 |
| 2020 Q2 | 54,900 | $199,000 | +$199,000 | $3.62 | 1 |